SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data

We compared the performance of SARS-CoV-2 neutralising antibody testing between 12 European laboratories involved in convalescent plasma trials. Raw titres differed almost 100-fold differences between laboratories when blind-testing 15 plasma samples. Calibration of titres in relation to the referen...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Dung, Simmonds, Peter, Steenhuis, Maurice, Wouters, Elise, Desmecht, Daniel, Garigliany, Mutien, Romano, Marta, Barbezange, Cyril, Maes, Piet, Van Holm, Bram, Mendoza, Joaquín, Oyonarte, Salvador, Fomsgaard, Anders, Lassaunière, Ria, Zusinaite, Eva, Resman Rus, Katarina, Avšič-Županc, Tatjana, Reimerink, Johan HJ, Brouwer, Fiona, Hoogerwerf, Marieke, Reusken, Chantal BEM, Grodeland, Gunnveig, Le Cam, Sophie, Gallian, Pierre, Amroun, Abdennour, Brisbarre, Nadège, Martinaud, Christophe, Leparc Goffart, Isabelle, Schrezenmeier, Hubert, Feys, Hendrik B, van der Schoot, C Ellen, Harvala, Heli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268650/
https://www.ncbi.nlm.nih.gov/pubmed/34240697
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.27.2100568

Ejemplares similares

Ejemplares similares